Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů

| 327.7 | L04AA12 | infliximab | parent. | 400 | MG | 112.732,00 | X | | 328 | L04AX | ostatní imunosupresiva | p.o. | L/J10,REV,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,56 | | | 31396 | IMURAN | tbl obd 100x25mg | BWE | GB | | | | | 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1,12 | | | 02418 | IMURAN | tbl obd 100x50mg | BWE | GB | | | | | 329 | L04AX | ostatní imunosupresiva | parent. | U/J10 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 329.1 | L04AX01 | azathioprin | parent. | 1 | MG | 9,82 | U/J10 | | 02016 | IMURAN | inj sic 1x50mg+2ml | BWE | GB | | | | | 330 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 330.1 | M01AA | butylpyrazolidiny | p.o. | 3 | DF | 3,32 | | | 330.2 | M01AA05 | klofezon | p.o. | 0.6 | GM | 3,32 | | | 331 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 331.1 | M01AA | butylpyrazolidiny | parent. | 1 | DF | 6,89 | | | 00490 | KETAZON | inj 5x5ml/1gm | LEX | CZ | | | | | 332 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | MG | 1,76 | | | | | | | | | | | | 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 3,18 | | | 77078 | APO-INDOMETHACIN 50MG | cps 100x50mg | APT | CND | | | | | 97713 | APO-INDOMETHACIN 25MG | cps 100x25mg | APT | CND | | | | | 67403 | INDOBENE 50MG | cps 20x50mg | MCK | D | | | | | 67404 | INDOBENE 50MG | cps 50x50mg | MCK | D | | | | | 332.3 | M01AB02 | sulindac | p.o. | 0.4 | GM | 4,69 | | | | | | | | | | | | 332.4 | M01AB03 | tolmetin | p.o. | 0.7 | GM | 4,69 | | | | | | | | | | | | 332.5 | M01AB05 | diklofenak | p.o. | 0.1 | GM | 4,29 | | | 75604 | DICLOFENAC AL 25 | tbl obd 50x25mg | APA | D | | | | | 75605 | DICLOFENAC AL 25 | tbl obd 100x25mg | APA | D | | | | | 96740 | APO-DICLO 25MG | tbl ent 100x25mg | APT | CND | | | | | 96742 | APO-DICLO 50MG | tbl ent 100x50mg | APT | CND | | | | | 89026 | DICLOFENAC AL 50 | tbl obd 100x50mg | APA | D | | | | | 75633 | DICLOFENAC AL RETARD | tbl obd 100x100mg | APA | D | | | | | 58426 | DOLMINA 25 | tbl obd 30x25mg | LEX | CZ | | | | | 58425 | DOLMINA 50 | tbl obd 30x50mg | LEX | CZ | | | | | 98144 | VERAL 25MG | tbl 30x25mg | SLO | SK | | | | | 83518 | VERAL 50MG | tbl ent 20x50mg | SLO | SK | | | | | 83519 | VERAL 50MG | tbl ent 50x50mg | SLO | SK | | | | | 332.6 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (do 100 MG v jedné tabletě včetně) | p.o. | 0.1 | GM | 4,52 | | | | | | | | | | | | 332.7 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (nad 100 MG v jedné tabletě) | p.o. | 0.1 | GM | 4,20 | | | | | | | | | | | | 332.8 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 4,29 | | | | | | | | | | | | 332.9 | M01AB09 | lonazolak | p.o. | 0.6 | GM | 4,29 | | | | | | | | | | | | 332.10 | M01AB16 | aceklofenak | p.o. | 0.2 | GM | 4,29 | | | | | | | | | | | | 332.11 | M01AB55 | diklofenak/misoprostol (na obsah diklofenaku) | p.o. | 0.1 | GM | 29,33 | Z | | 333 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 333.1 | M01AB01 | indometacin | p.rect. | 0.1 | GM | 3,27 | | | 02789 | INDOMETACINUM | sup 5x100mg | CHN | H | | | | | 96329 | INDOMETACIN | sup 10x100mg | BLU | CHO | | | | | 93724 | INDOMETACIN 100 BERLIN-CHEMIE | sup 10x100mg | BCE | D | | | | | 333.2 | M01AB03 | tolmetin | p.rect. | 0.7 | GM | 10,56 | | | | | | | | | | | | 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 10,56 | | | 66957 | MONOFLAM 100MG | sup 10x100mg | LIC | D | | | | | 66956 | MONOFLAM 50MG | sup 10x50mg | LIC | D | | | | | 87206 | VERAL 100MG | sup 10x100 | SLO | SK | | | | | 333.4 | M01AB09 | lonazolak | p.rect. | 0.6 | GM | 10,56 | | | 334 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 334.1 | M01AB01 | indometacin | parent. | 0.1 | GM | 12,66 | | | | | | | | | | | | 334.2 | M01AB05 | diklofenak | parent. | 0.1 | GM | 12,90 | | | 54539 | DOLMINA INJ. | inj 5x3ml/75mg | LEX | CZ | | | | | 67547 | ALMIRAL | inj 10x3ml/75mg | MOE | CY | | | | | 67548 | ALMIRAL | inj 100x3ml/75mg | MOE | CY | | | | | 76727 | DICLO 75 VON CT | inj 5x2ml/75mg | CTA | D | | | | | 98109 | NAKLOFEN | inj 5x3ml/75mg | KRK | SLO | | | | | 335 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 335.1 | M01AC01 | piroxikam | p.o. | 20 | MG | 2,49 | | | 97711 | APO-PIROXICAM 10 | cps 100x10mg | APT | CND | | | | | 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND | | | | | 91721 | ARTHREMIN 10 | cps 30x10mg | LEX | CZ | | | | | 71947 | ARTHREMIN 20 | cps 30x20mg | LEX | CZ | | | | | 84717 | HOTEMIN 20MG | cps 20x20mg | EGI | H | | | | | 31245 | HOTEMIN 10MG | cps 20x10mg | EGI | H | | | | | 53744 | PRO-ROXIKAM 10MG | tbl 20x10mg | PMP | CZ | | | | | 53745 | PRO-ROXIKAM 20MG | tbl 20x20mg | PMP | CZ | | | | | 68581 | PIROX 10 | tbl 50x10mg | CTA | D | | | | | 68582 | PIROX 20 | tbl 50x20mg | CTA | D | | | | | 47112 | PIROX 20 | tbl 20x20mg | MCK | D | | | | | 335.2 | M01AC02 | tenoxikam | p.o. | 20 | MG | 2,49 | | | | | | | | | | | | 335.3 | M01AC06 | meloxikam | p.o. | 15 | MG | 14,32 | L/ORT,REV,NEU | | | | | | | | | | | 335.4 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20 | MG | 4,52 | | | 336 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 336.1 | M01AC01 | piroxikam | p.rect. | 20 | MG | 10,75 | | | 67172 | PIROX 20 | sup 10x20mg | CTA | D | | | | | 336.2 | M01AC02 | tenoxikam | p.rect. | 20 | MG | 10,75 | | | | | | | | | | | | 336.3 | M01AC06 | meloxikam | p.rect. | 15 | MG | 14,32 | L/ORT,REV,NEU | | 337 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 337.1 | M01AC01 | piroxìkam | parent. | 20 | MG | 11,73 | | | 68649 | HOTEMIN | inj 5x1ml/20mg | EGI | H | | | | | 337.2 | M01AC02 | tenoxikam | parent. | 20 | MG | 11,73 | | | 338 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 338.1 | M01AE01 | ibuprofen | p.o. | 1.2 | GM | 3,57 | | | 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | | | | | 93651 | IBUPROFEN 400 LECIVA | tbl obd 30x400mg | LEX | CZ | | | | | 56035 | IBUPROFEN 600 LECIVA | tbl obd 30x600mg | LEX | CZ | | | | | 46983 | IBUPROFEN 400 LECIVA | tbl obd 100x400mg | LEX | CZ | | | | | 58250 | IBUPROFEN 600 LECIVA | tbl obd 100x600mg | LEX | CZ | | | | | 338.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.2 | GM | 19,55 | | | | | | | | | | | | 338.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.5 | GM | 4,29 | | | | | | | | | | | | 338.4 | M01AE02 | naproxen (tekuté lékové formy), | p.o. | 0.5 | GM | 13,15 | | | | | | | | | | | | 338.5 | M01AE03 | ketoprofen | p.o. | 0.15 | GM | 4,29 | | | | | | | | | | | | 338.6 | M01AE07 | suprofen | p.o. | 0.4 | GM | 4,29 | | | | | | | | | | | | 338.7 | M01AE08 | pirprofen | p.o. | 0.8 | GM | 4,29 | | | | | | | | | | | | 338.8 | M01AE09 | flurbiprofen | p.o. | 0.2 | GM | 4,29 | | | | | | | | | | | | 338.9 | M01AE10 | indoprofen | p.o. | 0.6 | GM | 4,29 | | | | | | | | | | | | 338.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.6 | GM | 6,70 | | | | | | | | | | | | 338.11 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 4,29 | | | 339 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 339.1 | M01AE01 | ibuprofen | p.rect. | 1.2 | GM | 9,38 | | | | | | | | | | | | 339.2 | M01AE02 | naproxen | p.rect. | 0.5 | GM | 10,75 | | | | | | | | | | | | 339.3 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 8,75 | | | 06171 | PROFENID 100MG | sup 12 | SPC | F | | | | | 67639 | KETOPROFEN VON CT | sup 10x100mg | CTA | D | | | | | 339.4 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.6 | GM | 10,75 | | | 340 | M01A | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové a fenamátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 340.1 | M01AE01 | ibuprofen | parent. | 1.2 | GM | 13,73 | | | | | | | | | | | | 340.2 | M01AE02 | naproxen | parent. | 0.5 | GM | 13,73 | | | 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 13,73 | | | 76657 | KETONAL I.M. | inj 10x2ml/100mg | LEK | SLO | | | | | 59443 | KETONAL | inj 5x2ml/100mg | LEK | SLO | | | | | 340.4 | M01AG | etofenamat | parent. | 1 | GM | 13,73 | | | 341 | M01AX | ostatní protizánětlivá léčiva | p.o. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 341.1 | M01AX01 | nabumeton | p.o. | 1 | GM | 15,60 | L/REV, ORT | | | | | | | | | | | 341.2 | M01AX04 | azapropazon | p.o. | 0.75 | GM | 11,78 | | | 31023 | PROLIXAN 300 | cps 30x300mg | IDA | H | | | | | 341.3 | M01AX05 | glukosamin sulfat | p.o. | 1.5 | GM | 11,44 | L/REV, ORT | | | | | | | | | | | 341.4 | M01AX13 | proquazon | p.o. | 0.9 | GM | 11,78 | | | | | | | | | | | | 341.5 | M01AX17 | nimesulid (pevné lékové formy) | p.o. | 0.2 | GM | 14,32 | L/REV,ORT,NEU | | | | | | | | | | | 341.6 | M01AX17 | nimesulid (tekuté lékové formy) | p.o. | 0.2 | GM | 19,55 | L/REV,PDD,NEU | | | | | | | | | | | 341.7 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,32 | L/REV,ORT,NEU | | | | | | | | | | | 341.8 | M01AH01 | celecoxib | p.o. | 0.2 | GM | 30,00 | P | | | | | | | | | | | 341.9 | M01AH | rofecoxib (pevné i tekuté lékové formy) | p.o. | 1 | DF | 30,00 | P |

Léčiva skupiny specifických COX 2 inhibitorů jsou předepisována revmatologem nebo ortopedem osobám s níže uvedeným rizikem:

1) prodělaná vředová choroba žaludku či duodena, ověřená fibroskopicky, v předchozích 20 letech života nebo současně, nebo

2) současná dlouhodobá celková léčba kortikoidy (t.j. déle než 6 - 8 týdnů), nebo

3) současná léčba antikoagulačními léky warfarinového typu.

Osobám s výše uvedeným rizikem jsou tato léčiva předepisována u následujících diagnóz:

• a) revmatoidní artritida dospělých ve všech stadiích onemocnění - celecoxib

• b) osteoartróza nosných kloubů rentgenologicky III. - IV. stadia dle Kellgrena ve stadiu bolestivé dekompenzace či zánětlivé iritace - celecoxib i rofecoxib.

| 341.10 | M01AX21 | diacerein | p.o. | 100 | MG | 6,70 | L/REV, ORT | | 342 | M01CB | léčiva obsahující zlato | parent. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,60 | L/REV | | 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | | | | | 02781 | TAUREDON | inj 10x0.5ml/20mg | BGL | D | | | | | 343 | M01C | penicilamin a ostatní chorobu modifikující léčiva včetně skupiny M09 | p.o., parent. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu kyselinou hyaluronovou ordinuje ortoped nebo revmatolog:

součást léčby primární osteoarthrózy kolenních klobů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.

| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 32,50 | | | 66755 | METALCAPTASE | tbl obd 50x150mg | KNO | D | | | | | 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 22,88 | | | | | | | | | | | | 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 195,52 | P | | 343.4 | M09AX02 | chondroitin sulfat | p.o. | 1.6 | GM | 14,66 | L/REV,ORT | | 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití, nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.2 | M02AA | ketofenylbutazon do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.3 | M02AA | kombinace ibuprofenu a heparinoidu do 50 g včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.4 | M02AA05 | benzydamin | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.5 | M02AA06 | etofenamát do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.6 | M02AA06 | etofenamát nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.7 | M02AA07 | piroxikam do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.8 | M02AA07 | piroxikam nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | 01780 | REUMADOR | gel 1x100gm | SLO | SK | | | | | 344.9 | M02AA10 | ketoprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.10 | M02AA10 | ketoprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.11 | M02AA10 | ketoprofen spray (dle obsahu ketoprofenu) | lok. | 150 | MG | 5,50 | | | | | | | | | | | | 344.12 | M02AA13 | ibuprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.13 | M02AA13 | ibuprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.14 | M02AA15 | diklofenak do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | 67549 | ALMIRAL GEL | gel 1x25gm | MOE | CY | | | | | 344.15 | M02AA15 | diklofenak nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | 65985 | VERAL GEL | gel 1x100gm 1% | SLO | SK | | | | | 67550 | ALMIRAL GEL | gel 1x250gm | MOE | CY | | | | | 344.16 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2 | DF | 5,08 | | | | | | | | | | | | 344.17 | M02AA17 | kyselina niflumová nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.18 | M02AA21 | tolectin do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.19 | M02AA21 | tolectin nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | | | | | | | | | | | | 344.20 | M02AA23 | indomethacin do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | | | | | | | | | | | | 344.21 | M02AA23 | indomethacin nad 50 g masti v jednom baleni | lok. | 1 | UM | 0,70 | | | 345 | M02AC | deriváty kyseliny salicylové k lokálnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 345.1 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1 | GM | 0,85 | | | 03574 | RHEUMOSIN | ung 1x30gm | LEX | CZ | | | | | 346 | M02AX | jiná léčiva k léčbě kloubů a svalů k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 346.1 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1 | GM | 0,85 | | | 91114 | VIPROSAL B | ung 1x50gm | TAL | EST | | | | | 83872 | UNGUENTUM CAMPHORATUM 10% MVM | ung 1x1 kg | MVM | CZ | | | | | 346.2 | M02AX10 | různé | lok. | 1 | GM | 0,34 | | | 00803 | PAIN EXPELLER | liq 1x50ml | GNO | CZ | | | | | 347 | M03AA | svalová relaxancia ze skupiny kurarových alkaloidů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 347.1 | M03AA01 | alkuronium | parent. | 20 | MG | 70,43 | H | | | | | | | | | | | 347.2 | M03AA02 | tubokurarin | parent. | 30 | MG | 55,82 | H | | 348 | M03AB | svalová relaxancia ze skupiny derivativátů cholinu | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 348.1 | M03AB | decamethonium | parent. | 10 | MG | 23,76 | H | | | | | | | | | | | 348.2 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100 | MG | 63,84 | H | | | | | | | | | | | 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 36,51 | H | | 97387 | SUCCINYLCHOLINJODID VUAB | inj 1x250mg | VUA | CZ | | | | | 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniových derivátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 349.1 | M03AC01 | pankuronium | parent. | 10 | MG | 113,59 | H | | | | | | | | | | | 349.2 | M03AC02 | gallamin | parent. | 100 | MG | 43,11 | H | | | | | | | | | | | 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 113,59 | H | | | | | | | | | | | 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 110,61 | H | | 86761 | TRACRIUM | inj 5x5ml/50mg | BWE | GB | | | | | 86760 | TRACRIUM | inj 5x2.5ml/25mg | BWE | GB | | | | | 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 103,48 | H | | | | | | | | | | | 349.6 | M03AC10 | mivacuronium | parent. | 10 | MG | 129,58 | H | | | | | | | | | | | 349.7 | M03AC11 | cisatracurium | parent. | 10 | MG | 208,40 | H | | 350 | M03AX | ostatní svalová relaxancia | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 9580,28 | X | | 75241 | BOTOX | inj sic 1x100ut | ABL | IRL | | | | | 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2443,95 | X | | 97456 | DYSPORT | inj sic 2x500ut | SPY | GB | | | | | 351 | M03BX | jiná centrálně působící svalová relaxancia | p.o. | L/NEU,ORT,REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 351.1 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50 | MG | 9,97 | | | | | | | | | | | | 351.2 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50 | MG | 6,31 | | | | | | | | | | | | 351.3 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 21,50 | L/NEU,ORT,REV | | | | | | | | | | | 351.4 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 15,84 | L/NEU,ORT,REV | | | | | | | | | | | 351.5 | M03BX04 | tolperison | p.o. | 200 | MG | 4,38 | | | 00208 | MYDOCALM | tbl obd 30x50mg | GED | H | | | | | 03788 | MYDOCALM 150 | tbl ent 30x150mg | GED | H | | | | | 57785 | MYDOCALM 50MG | tbl obd 30x50mg-le. | GED | H | | | | | 351.6 | M03BX04 | tolperison | parent. | 200 | MG | 9,58 | | | 02755 | MYDOCALM | inj 5x1ml/100mg | GED | H | | | | | 351.7 | M03BX05 | thiocolchicosid | p.o. | 12 | MG | 9,97 | | | | | | | | | | | | 351.8 | M03BX05 | thiocolchicosid | parent. | 12 | MG | 39,10 | | | | | | | | | | | | 351.9 | M03BX07 | tetrazepam | p.o. | 0.1 | GM | 15,84 | L/NEU,ORT,REV | | 56233 | MYOLASTAN | tbl obd 10x50mg | SWI | F | | | | | 351.10 | M03BC51 | orfenadrini citras a diklofenak | parent. | 1 | DF | 200,00 | H | | 352 | M03CA | přímo působící svalová relaxancia | parent. | T | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7156,08 | T | | 91583 | DANTROLEN | inj sic3x12x20mg+so | RHA | D | | | | | 353 | M04AA | antiuratika inhibující tvorbu kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,28 | | | 96332 | ALOPURINOL BELUPO | tbl 100x100mg | BLU | CHO | | | | | 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 354.1 | M04AB02 | sulfinpyrazon | p.o. | 0.3 | GM | 5,08 | | | | | | | | | | | | 354.2 | M04AB03 | benzbromaron | p.o. | 0.1 | GM | 1,86 | | | 355 | M04AC | léčiva užívaná při léčbě dnavého záchvatu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 5,91 | | | 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | KCH | D | | | | | 356 | M05BA | bisfosfonáty | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

M05BA02 - kyselina klodronová, M05BA06 kyselina ibandronová:

Léčbu ordinuje onkolog, hematolog, internista, ortoped:

Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo bez nich; mnohočetný myelom.

M05BA04 - kyselina alendronová:

Léčbu ordinuje internista, ortoped, revmatolog, endokrinolog:

• a) Denzitometricky dokumentovaná osteoporóza nebo osteoporotická patologická zlomenina.

• b) Ženy o osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii.

Výše uvedená léčba kyselinou alendronovou je dlouhodobá, minimálně po dobu jednoho roku. Terapie delší než jeden rok je indikována pouze pokud u pacienta prokazatelně zastavila úbytek kostní hmoty.

M05BA03 - kyselina pamidronová:

Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog, endokrinolog:

• a) Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázemi nebo bez nich; mnohočetný myelom.

• b) Manifestní Pagetova choroba.

| 356.1 | M05BA02 | kyselina klodronová | p.o. | 1.6 | GM | 225,58 | P | | 93985 | LODRONAT | cps 60x500mg | BOM | A | | | | | 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | | | | | 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 44,90 | P | | 357 | M05BA | bisfosfonáty | parent. | O/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

M05BA02 - kyselina klodronová, M05BA06 kyselina ibandronová:

Léčbu ordinuje onkolog, hematolog, internista, ortoped:

Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo bez nich; mnohočetný myelom.

M05BA04 - kyselina alendronová:

Léčbu ordinuje internista, ortoped, revmatolog, endokrinolog:

• a) Denzitometricky dokumentovaná osteoporóza nebo osteoporotická patologická zlomenina.

• b) Ženy o osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii.

Výše uvedená léčba kyselinou alendronovou je dlouhodobá, minimálně po dobu jednoho roku. Terapie delší než jeden rok je indikována pouze pokud u pacienta prokazatelně zastavila úbytek kostní hmoty.

M05BA03 - kyselina pamidronová:

Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog, endokrinolog:

• a) Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázemi nebo bez nich; mnohočetný myelom.

• b) Manifestní Pagetova choroba.

| 357.1 | M05BA02 | kyselina klodronová | parent. | 1.5 | GM | 2348,73 | O/P | | 94548 | BONEFOS | inj 5x5ml 60mg/ml | STF | SF | | | | | 93972 | LODRONAT | inj 5x10ml | BOM | A | | | | | 57452 | LODRONAT AMPULE | inj 5x10ml | BOM | D | | | | | 357.2 | M05BA03 | kyselina pamidronová | parent. | 60 | MG | 3758,01 | O/P | | | | | | | | | | | 357.3 | M05BA06 | kyselina ibandronová | parent. | 2 | MG | 9384,77 | O/P | | 358 | N01AA | inhalační anestetika ze skupiny etherů | inhal. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 358.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100 | GM | 15,45 | H | | 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 304,96 | H | | 75284 | NARCOTAN | liq 1x250ml | LEX | CZ | | | | | 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 2290,62 | H | | | | | | | | | | | 359.3 | N01AB08 | sevofluoran | inhal. | 100 | ML | 2290,62 | H | | 360 | N01AF | injkeční anestetika ze skupiny barbiturátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 142,63 | H | | 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 60,41 | H | | 97388 | THIOPENTAL VUAB | inj sic 1x500mg | VUA | CZ | | | | | 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 34,95 | H | | 97389 | THIOPENTAL VUAB | inj sic 1x1gm | VUA | CZ | | | | | 361 | N01AH | opioidní anestetika (fentanyl) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 361.1 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 119,41 | O | | 01449 | FENTANYL | inj 50x10ml/0.5mg | JAN | B | | | | | 60911 | FENTANYL | inj 5x10ml/0.5mg | JAN | B | | | | | 361.2 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 173,62 | O | | 76527 | FENTANYL | inj 50x2ml/0.1mg | JAN | B | | | | | 362 | N01AH | opioidní anestetika (ostatní) | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 48,29 | H | | 87721 | RAPIFEN | inj 5x2ml | JAN | B | | | | | 362.2 | N01AH03 | sufentanyl (do 10 RG v ampuli včetně) | parent. | 0.6 | MG | 1383,67 | H | | 93701 | SUFENTA I.V. | inj 5x2ml/10rg | JAN | B | | | | | 362.3 | N01AH03 | sufentanyl (nad 50 RG v ampuli) | parent. | 0.6 | MG | 740,22 | H | | 93702 | SUFENTA FORTE I.V. | inj 5x5ml/250rg | JAN | B | | | | | 362.4 | N01AH03 | sufentanyl (nad 10 do 50 RG v ampuli včetně) | parent. | 0.6 | MG | 1210,83 | H | | 85526 | SUFENTA FORTE I.V. | inj 5x1ml/50rg | JAN | B | | | | | 93703 | SUFENTA I.V. | inj 5x10ml/50rg | JAN | B | | | | | 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 38,22 | H | | | | | | | | | | | 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 264,29 | H | | 56741 | ULTIVA 5MG | inj sic 5x5mg | GWE | GB | | | | | 56740 | ULTIVA 2MG | inj sic 5x2mg | GWE | GB | | | | | 363 | N01AX | ostatní celková anestetika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 363.1 | N01AX03 | ketamin (koncetrace do 1 % včetně) | parent. | 100 | ML | 240,19 | O | | 64824 | NARKAMON 1% INJ. | inj 10x10ml/100mg | SPX | CZ | | | | | 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 10 | ML | 117,02 | O | | | | | | | | | | | 363.3 | N01AX04 | propanidid | parent. | 1 | GM | 32,11 | O | | | | | | | | | | | 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 162,72 | O | | | | | | | | | | | 363.5 | N01AX10 | propofol | parent. | 10 | ML | 96,14 | O | | 53441 | PROPOFOL ABBOTT | inj 5x20ml/200mg-am | ABN | USA | | | | | 53442 | PROPOFOL ABBOTT | inj 5x20ml/200mg-la | ABN | USA | | | | | 53443 | PROPOFOL ABBOTT | inj 1x50ml/500mg | ABN | USA | | | | | 53444 | PROPOFOL ABBOTT | inj 1x100ml/1gm | ABN | USA | | | | | 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 19,55 | O | | | | | | | | | | | 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O | | 00564 | PROCAIN LECIVA 1% | inj 10x5ml 1% | LEX | CZ | | | | | 00565 | PROCAIN LECIVA 1% | inj 10x10ml 1% | LEX | CZ | | | | | 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,54 | O | | 69669 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 1x80ml 0.2% | ARD | CZ | | 69670 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 1x250ml 0.2% | ARD | CZ | | 69671 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 1x500ml 0.2% | ARD | CZ | | 69673 | INJECTIO | PROCAIN | CHLOR | .0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | 69674 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | 69676 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 1x250ml 1% | ARD | CZ | | 69677 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 1x500ml 1% | ARD | CZ | | 86437 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 40x80ml 0.2% | ARD | CZ | | 86444 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 20x250ml 0.2% | ARD | CZ | | 86445 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 12x500ml 0.2% | ARD | CZ | | 86447 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | 86448 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | 86450 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 20x250ml 1% | ARD | CZ | | 86451 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 12x500ml 1% | ARD | CZ | | 89212 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 1x200ml 0.2% | ARD | CZ | | 89213 | INJECTIO | PROCAIN | CHLOR | 0.2% ARD | inj 20x200ml 0.2% | ARD | CZ | | 89214 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 1x200ml 0.5% | ARD | CZ | | 89215 | INJECTIO | PROCAIN | CHLOR | 0.5% ARD | inj 20x200ml 0.5% | ARD | CZ | | 89216 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 1x200ml 1% | ARD | CZ | | 89217 | INJECTIO | PROCAIN | CHLOR | 1% ARD. | inj 20x200ml 1% | ARD | CZ | | 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,22 | O | | 02684 | MESOCAIN | gel 1x20gm | SLO | SK | | | | | 365.2 | N01BB02 | lidokain | lok. | 1 | ML | 7,83 | O | | 62393 | INSTILLAGEL | gel 10x11ml(strik.) | FAP | D | | | | | 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,73 | O | | 69704 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | | | | | 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | | | 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | | | 86452 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 40x80ml 0.5% | ARD | CZ | | | | | 86453 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | | | | 86454 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | | | | 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O | | 00502 | MESOCAIN | inj 10x10ml 1% | LEX | CZ | | | | | 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,78 | O | | 69707 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x80ml 1% | ARD | CZ | | | | | 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | | | 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1 x500ml 1 % | ARD | CZ | | | | | 86455 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 40x80ml 1 % | ARD | CZ | | | | | 86456 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 20x250ml 1% | ARD | CZ | | | | | 86457 | INJECTIO TRIMECAIN.CHL. 1 % ARD. | inj 12x500ml 1% | ARD | CZ | | | | | 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,22 | O | | 00503 | MESOCAIN | inj 10x5ml 2% | LEX | CZ | | | | | 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,35 | O | | | | | | | | | | | 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,52 | O | | | | | | | | | | | 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 49,66 | O | | 92836 | MARCAINE SPINAL 0.5% HEAVY | inj 5x4ml/20mg | AST | S | | | | | 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,22 | O | | | | | | | | | | | 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,52 | O | | | | | | | | | | | 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,15 | O | | | | | | | | | | | 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 10,22 | O | | 91234 | ULTRACAIN HYPERBAR 5% | inj 10x2ml/100mg | HOE | D | | | | | 366.12 | N01BB51 | bupivakain/adrenalin | parent. | 1 | ML | 3,81 | O | | | | | | | | | | | 366.13 | N01BB52 | lidokain/adrenalin | parent. | 1 | ML | 2,35 | O | | | | | | | | | | | 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,15 | O | | 93109 | SUPRACAIN 4% | inj 10x2ml | LEX | CZ | | | | | 366.15 | N01BB09 | ropivacain | parent. | 1 | ML | 15,64 | O | | 56038 | NAROPIN 2MG/ML | inj 5x10ml/20mg | APN | S | | | | | 367 | N01BX | ostatní lokální anestetika | lok. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 93,36 | O | | 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 79,40 | | | 55939 | M-ESLON SR 10 | cps ret 50x10mg | ETP | F | | | | | 55940 | M-ESLON SR 10 | cps ret 100x10mg | ETP | F | | | | | 80405 | VENDAL RETARD | tbl fc 30x10mg | LAR | D | | | | | 88834 | M-ESLON SR 10 | cps ret 20x10mg | ETP | F | | | | | 94309 | MST CONTINUS | tbl 60x10mg | NPP | GB | | | | | 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 53,20 | | | 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK | | | | | 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK | | | | | 55941 | M-ESLON SR 30 | cps ret 50x30mg | ETP | F | | | | | 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F | | | | | 80406 | VENDAL RETARD | tbl fc 30x30mg | LAR | D | | | | | 88835 | M-ESLON SR 30 | cps ret 20x30mg | ETP | F | | | | | 94310 | MST CONTINUS | tbl 60x30mg | NPP | GB | | | | | 368.3 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 | | | 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK | | | | | 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK | | | | | 55945 | M-ESLON SR 100 | cps ret 50x100mg | ETP | F | | | | | 55946 | M-ESLON SR 100 | cps ret 100x100mg | ETP | F | | | | | 80408 | VENDAL RETARD | tbl fc 30x100mg | LAR | D | | | | | 88842 | M-ESLON SR 100 | cps ret 20x100mg | ETP | F | | | | | 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB | | | | | 368.4 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 | | | 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK | | | | | 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK | | | | | 55943 | M-ESLON SR 60 | cps ret 50x60mg | ETP | F | | | | | 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | | | | | 80407 | VENDAL RETARD | tbl fc 30x60mg | LAR | D | | | | | 88839 | M-ESLON SR 60 | cps ret 20x60mg | ETP | F | | | | | 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | | | | | 368.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 61,60 | | | | | | | | | | | | 368.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 58,36 | | | | | | | | | | | | 368.7 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, 100 a více mg v jedné dávce) | p.o. | 0.1 | GM | 53,90 | | | | | | | | | | | | 368.8 | N02AA01 | morfin (tekuté lékové formy, do 200 mg včetně v jednom balení) | p.o. | 0.1 | GM | 39,10 | | | | | | | | | | | | 368.9 | N02AA01 | morfin (tekuté lékové formy, nad 200 mg v jednom balení) | p.o. | 0.1 | GM | 17,60 | | | | | | | | | | | | 368.10 | N02AA05 | oxycodon do 20 mg v jedné tabletě včetně | p.o. | 30 | MG | 57,20 | | | | | | | | | | | | 368.11 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 30 | MG | 52,64 | | | | | | | | | | | | 368.12 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 48,74 | | | | | | | | | | | | 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 52,34 | | | 80451 | DHC CONTINUS 60MG | tbl 56x60mg | NPP | GB | | | | | 56873 | DHC CONTINUS 60MG | tbl ret 20x60mg | NPP | GB | | | | | 56874 | DHC CONTINUS 90MG | tbl ret 20x90mg | NPP | GB | | | | | 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.24 | GM | 44,58 | | | 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 14,88 | O | | 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK | | | | | 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,00 | O | | 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK | | | | | 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 41,30 | | | | | | | | | | | | 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1 | DF | 241,46 | P | | | | | | | | | | | 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 458,80 | P | | | | | | | | | | | 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 667,20 | P | | | | | | | | | | | 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 807,50 | P |

Lék je aplikován v případech, kdy pacient není schopen perorálního příjmu opioidů.

Topiramat - léková forma tobolky, síla do 25 mg včetně v jedné tobolce: Pro děti předškolního věku, které nemohou být, z jakýchkoliv důvodů, léčeny tabletovou formou.